NCT03767374 - Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs | Biotech Hunter

Enrollment

2,186

Participants

Timeline

Start Date

May 11, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2020

Conditions

Bacterial InfectionsHIV Infections

Interventions

PROCEDURE

Inguinal swab sample

Inguinal samples using swab at cross-sectional visit

PROCEDURE

Anal swab sample

Anal samples using swab at cross-sectional visit and at 6-month visit (for those with ESBL and/or CRE colonization)

PROCEDURE

Fecal sample

Fecal sample at cross-sectional visit and at 6-month visit (for those with ESBL and/or CRE colonization)

OTHER

Risk factor assessment

Patients will be asked questions on risk factors associated with MDR/XDR colonization at cross-sectional visit and at 6-month visit (for those with ESBL and/or CRE colonization

Trial Locations (1)

75012

CeGIDD and Infections Diseases Unit, Paris

All Listed Sponsors

collaborator

ANRS, Emerging Infectious Diseases

OTHER_GOV

lead

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

OTHER